A critical breakthrough in cancer study is occurring with the use of mini-antibodies to re-engage dysfunctional p53. This vital tumor inhibitor protein is frequently inactivated in many types of cancer, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research